These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 14720075)

  • 1. Asthma refractory to glucocorticoids: the role of newer immunosuppressants.
    Corrigan CJ
    Am J Respir Med; 2002; 1(1):47-54. PubMed ID: 14720075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma.
    Haczku A; Alexander A; Brown P; Assoufi B; Li B; Kay AB; Corrigan C
    J Allergy Clin Immunol; 1994 Feb; 93(2):510-9. PubMed ID: 8120277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
    Powell N; Till S; Bungre J; Corrigan C
    J Allergy Clin Immunol; 2001 Dec; 108(6):915-7. PubMed ID: 11742267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents.
    Corrigan CJ; Bungre JK; Assoufi B; Cooper AE; Seddon H; Kay AB
    Eur Respir J; 1996 Oct; 9(10):2077-86. PubMed ID: 8902470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation as asthma therapy: where do we stand?
    Barnes PJ
    Eur Respir J Suppl; 1996 Aug; 22():154s-159s. PubMed ID: 8871062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel immunosuppressants in asthma.
    Kon OM
    Chem Immunol; 2000; 78():124-34. PubMed ID: 12847724
    [No Abstract]   [Full Text] [Related]  

  • 7. Methotrexate in the treatment of systemic glucocorticoid-dependent severe persistent asthma: a word of caution.
    Fabbri L; Caramori G; Cosma P; Ciaccia A
    Monaldi Arch Chest Dis; 1996 Apr; 51(2):130-7. PubMed ID: 8680380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of activation markers and cytokine mRNA by peripheral blood CD4 and CD8 T cells in atopic and nonatopic childhood asthma: effect of inhaled glucocorticoid therapy.
    Gemou-Engesaeth V; Fagerhol MK; Toda M; Hamid Q; Halvorsen S; Groegaard JB; Corrigan CJ
    Pediatrics; 2002 Feb; 109(2):E24. PubMed ID: 11826234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin.
    Spahn JD; Leung DY; Chan MT; Szefler SJ; Gelfand EW
    J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):421-6. PubMed ID: 10069875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma.
    Nair P; Wenzel S; Rabe KF; Bourdin A; Lugogo NL; Kuna P; Barker P; Sproule S; Ponnarambil S; Goldman M;
    N Engl J Med; 2017 Jun; 376(25):2448-2458. PubMed ID: 28530840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
    Corrigan CJ; Shiner RJ; Shakur BH; Ind PW
    Clin Exp Allergy; 2005 May; 35(5):579-84. PubMed ID: 15898978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate therapy in asthma increases T cell susceptibility to corticosteroid inhibition.
    Corrigan CJ; Shiner R; Shakur BH; Ind PW
    Clin Exp Allergy; 2003 Aug; 33(8):1090-6. PubMed ID: 12911783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of the immune system by oral glucocorticoid therapy in bronchial asthma.
    Oehling AG; Akdis CA; Schapowal A; Blaser K; Schmitz M; Simon HU
    Allergy; 1997 Feb; 52(2):144-54. PubMed ID: 9105518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy.
    Doi S; Gemou-Engesaeth V; Kay AB; Corrigan CJ
    Clin Exp Allergy; 1994 Sep; 24(9):854-67. PubMed ID: 7812887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current management of asthma patients with corticosteroid resistance.
    Busse WW; McGill K; Jarjour NN
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 2):S70-2; discussion S72-3. PubMed ID: 8756793
    [No Abstract]   [Full Text] [Related]  

  • 18. Alternative treatments in the patient with intractable asthma.
    Spector SL
    Curr Opin Pulm Med; 1997 Jan; 3(1):23-9. PubMed ID: 9139769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose methotrexate treatment in severe glucocorticoid-dependent asthma: effect on mucosal inflammation and in vitro sensitivity to glucocorticoids of mitogen-induced T-cell proliferation.
    Vrugt B; Wilson S; Bron A; Shute J; Holgate ST; Djukanovic R; Aalbers R
    Eur Respir J; 2000 Mar; 15(3):478-85. PubMed ID: 10759440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients.
    Xystrakis E; Kusumakar S; Boswell S; Peek E; Urry Z; Richards DF; Adikibi T; Pridgeon C; Dallman M; Loke TK; Robinson DS; Barrat FJ; O'Garra A; Lavender P; Lee TH; Corrigan C; Hawrylowicz CM
    J Clin Invest; 2006 Jan; 116(1):146-55. PubMed ID: 16341266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.